San Jose CA, USA: February 2, 2023 – Benchmark WES re-analysis study with OmniTier’s AI-based variant interpretation platform achieves around a 42% diagnostics rate, a 7% improvement in the average rate for diagnosing rare diseases
Ann Arbor, Michigan – Genomenon®, Inc., an AI-driven genomics company, announced a partnership with OmniTier, which includes integration of the Mastermind® Genomic Search Engine into their on-premises based CompStor Insight® genomics analysis platform.
(BAY AREA, CA, USA: In response to requirements from some competing human genomics analysis providers to allow them certain usage rights over the customer’s data, OmniTier announces that customers using its secondary analysis and variant interpretation appliances, CompStor Novos® and CompStor Insight® keep full control and ownership of all their data.